Related Experiment Video
Updated: Aug 9, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
ERK1/2 activation attenuates TRAIL-induced apoptosis through the regulation of mitochondria-dependent pathway
Do Yeon Lee1, Myoung Woo Lee, Hyun Jung Lee
1Department of Anatomy and Cell Biology, College of Medicine, Chung-Ang University, 221 Huksuk-dong, Dongjak-ku, Seoul 156-756, Republic of Korea.
Abstract:
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) functions as an extracellular signal, which triggers apoptosis in tumor cells. In order to characterize the molecular events involved in TRAIL cytotoxic signaling, we attempted to determine the role of extracellular signal-regulated kinase 1/2 (ERK1/2), as well as its downstream targets in TRAIL-treated HeLa cells. Here we demonstrate that TRAIL exposure resulted in the activation of ERK1/2, and the elevation of anti-apoptotic Bcl-2 protein levels. ERK1/2 inhibition with PD98059 promoted cell death via the down-regulation of Bcl-2 protein levels, together with increasing mitochondrial damage, including the collapse of mitochondrial membrane potential, the release of cytochrome c from mitochondria to cytoplasm and caspase activity. These results suggest that the ERK1/2 activation is a kind of survival mechanism to struggle against TRAIL-induced stress condition in early stage, via activating cellular defense mechanisms like as the up-regulation of the Bcl-2/Bax ratio, as well as several mitochondrial events.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis. Extracellular signal-regulated kinase 1/2 (ERK1/2) activation acts as a survival mechanism, upregulating Bcl-2 to protect cells from TRAIL-induced death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces programmed cell death (apoptosis) in cancer cells.
- Understanding the molecular pathways of TRAIL-induced apoptosis is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of extracellular signal-regulated kinase 1/2 (ERK1/2) in TRAIL-mediated apoptosis.
- To identify downstream targets of ERK1/2 involved in TRAIL signaling.
Main Methods:
- HeLa cells were treated with TRAIL.
- ERK1/2 activation and downstream targets were analyzed.
- Mitochondrial integrity and caspase activity were assessed following ERK1/2 inhibition using PD98059.
Main Results:
- TRAIL exposure activated ERK1/2 and increased anti-apoptotic Bcl-2 protein levels.
- Inhibiting ERK1/2 with PD98059 led to increased cell death.
- ERK1/2 inhibition caused mitochondrial damage, cytochrome c release, and enhanced caspase activity.
Conclusions:
- ERK1/2 activation serves as an early-stage survival mechanism against TRAIL-induced stress.
- This survival pathway involves upregulating the Bcl-2/Bax ratio and modulating mitochondrial events.
- Targeting ERK1/2 could potentially enhance TRAIL-based cancer treatments.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Caspases
Apoptosis
Regulation of the Unfolded Protein Response

